Workflow
American Shared Hospital Services(AMS) - 2025 Q1 - Quarterly Results

Revenue Growth - FY 2024 revenue increased 32.9% year over year to 28.34million,upfrom28.34 million, up from 21.33 million in FY 2023[5] - Revenue from direct patient services segment surged 253.4% year over year to 12.56million,comparedto12.56 million, compared to 3.55 million in FY 2023[5] - Q4 2024 revenue increased 59.2% to 9.07millioncomparedto9.07 million compared to 5.70 million in Q4 2023, driven by expanded radiation therapy services[11] - Q4 2024 revenue from direct patient services segment was 4.75million,a420.24.75 million, a 420.2% increase from the same period last year[12] Net Income and Earnings - Net income attributable to the company for FY 2024 rose 258.4% to 2.19 million, or 0.34perdilutedshare,comparedto0.34 per diluted share, compared to 610,000, or 0.10perdilutedshareinFY2023[9]TheoverallnetincomeforthetwelvemonthsendedDecember31,2024,was0.10 per diluted share in FY 2023[9] - The overall net income for the twelve months ended December 31, 2024, was 2,186,000, compared to 610,000in2023,representinganincreaseofapproximately258.7610,000 in 2023, representing an increase of approximately 258.7%[28] Adjusted EBITDA - Adjusted EBITDA for FY 2024 increased 8.5% to 8.89 million from 8.19millioninFY2023[10]AdjustedEBITDAforthetwelvemonthsendedDecember31,2024,was8.19 million in FY 2023[10] - Adjusted EBITDA for the twelve months ended December 31, 2024, was 8,885,000, up from 8,189,000in2023,reflectingayearoveryearincreaseofapproximately8.58,189,000 in 2023, reflecting a year-over-year increase of approximately 8.5%[28] Cash and Equity - Cash, cash equivalents, and restricted cash totaled 11.28 million as of December 31, 2024, down from 13.81millionayearearlier[16]Shareholdersequityincreasedto13.81 million a year earlier[16] - Shareholders' equity increased to 25.18 million or 3.92peroutstandingshareatDecember31,2024,comparedto3.92 per outstanding share at December 31, 2024, compared to 22.62 million or 3.59pershareatDecember31,2023[16]ExpensesandLossesInterestexpenseincreasedto3.59 per share at December 31, 2023[16] Expenses and Losses - Interest expense increased to 1,499,000 for the twelve months ended December 31, 2024, compared to 1,112,000in2023,representingariseofabout34.81,112,000 in 2023, representing a rise of about 34.8%[28] - Depreciation and amortization expense for the three months ended December 31, 2024, was 1,673,000, an increase from 1,291,000inthesameperiodof2023,showingagrowthofapproximately29.61,291,000 in the same period of 2023, showing a growth of approximately 29.6%[28] - Loss on write down of impaired assets and associated removal costs for the three months ended December 31, 2024, was 2,896,000, compared to 362,000inthesameperiodof2023,indicatingasubstantialincrease[28]TaxandInterestIncomeIncometaxbenefitforthethreemonthsendedDecember31,2024,was362,000 in the same period of 2023, indicating a substantial increase[28] Tax and Interest Income - Income tax benefit for the three months ended December 31, 2024, was (71,000), a decrease from 338,000in2023,reflectingachangeintaxposition[28]InterestincomeforthetwelvemonthsendedDecember31,2024,was338,000 in 2023, reflecting a change in tax position[28] - Interest income for the twelve months ended December 31, 2024, was (342,000), down from (458,000)in2023,indicatingadecreaseofapproximately25.3(458,000) in 2023, indicating a decrease of approximately 25.3%[28] Stock-Based Compensation and Gains - Stock-based compensation expense for the twelve months ended December 31, 2024, was 373,000, slightly down from 389,000in2023,showingadecreaseofabout4.1389,000 in 2023, showing a decrease of about 4.1%[28] - The company reported a bargain purchase gain of (148,000) for the three months ended December 31, 2024, compared to no gain in the same period of 2023[28]